Nobel winner Sakaguchi pushes for more effective cancer treatment
Japanese Nobel laureate Shimon Sakaguchi, based in Suita, Osaka Prefecture, Japan, plans to use his discovery of regulatory T cells to develop effective cancer immunotherapy. In an interview with Jiji Press ahead of the Nobel Prize ceremony in Stockholm, he outlined research efforts to modulate regulatory T cells to boost antitumor immunity while limiting autoimmune side effects. Sakaguchi said he will expand international collaboration, pursue clinical applications, and continue studies on how regulatory T cells affect various cancers and immune-related diseases.